These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11011995)

  • 21. An in vitro investigation into the potential for bimodal drug release from pectin/chitosan/HPMC-coated tablets.
    Macleod GS; Fell JT; Collett JH
    Int J Pharm; 1999 Oct; 188(1):11-8. PubMed ID: 10528078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation of diltiazem hydrochloride delayed-onset, sustained release tablet].
    Zhang N; Zhu JB
    Yao Xue Xue Bao; 2002 Sep; 37(9):724-7. PubMed ID: 12567900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
    Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
    J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of an artificial neural network in the design of sustained-release dosage forms].
    Wei XH; Wu JJ; Liang WQ
    Yao Xue Xue Bao; 2001 Sep; 36(9):690-4. PubMed ID: 12580110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
    Hamed R; Al Baraghthi T; Sunoqrot S
    Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
    McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
    Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral sustained-release bioadhesive tablet formulation of didanosine.
    Betageri GV; Deshmukh DV; Gupta RB
    Drug Dev Ind Pharm; 2001 Feb; 27(2):129-36. PubMed ID: 11266224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and in vivo evaluation of omeprazole buccal adhesive tablet.
    Choi H; Jung J; Yong CS; Rhee C; Lee M; Han J; Park K; Kim C
    J Control Release; 2000 Sep; 68(3):405-12. PubMed ID: 10974394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naproxen availability from variable-dose and weight sustained-release tablets.
    Amaral MH; Lobo JM; Ferreira DC
    Drug Dev Ind Pharm; 2001; 27(3):221-5. PubMed ID: 11291202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation.
    Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC; Takayama K
    Eur J Pharm Biopharm; 2004 Nov; 58(3):607-14. PubMed ID: 15451535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonism.
    Cutler NR; Reines SA; McLean LF; Sramek JJ; Porras AG; Hand EL
    Clin Pharmacokinet; 1992 Mar; 22(3):223-30. PubMed ID: 1348452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel buccal adhesive tablets using Aloe vera L and Sinapis alba--a promising option for improved bioavailability of diltiazem hydrochloride.
    Sudhakar Y; Bandyopadhyay AK
    PDA J Pharm Sci Technol; 2008; 62(2):97-110. PubMed ID: 18540536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of HPMC particle size on the drug release rate and the percolation threshold in extended-release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Jan; 41(1):70-8. PubMed ID: 24134563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
    Williams RO; Sykora MA; Mahaguna V
    AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hot-melt extruded ethylcellulose cylinders containing a HPMC-Gelucire core for sustained drug delivery.
    Mehuys E; Vervaet C; Remon JP
    J Control Release; 2004 Feb; 94(2-3):273-80. PubMed ID: 14744479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets.
    Macleod GS; Fell JT; Collett JH; Sharma HL; Smith AM
    Int J Pharm; 1999 Oct; 187(2):251-7. PubMed ID: 10502631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synchronized release of sulpiride and sodium decanoate from HPMC matrices: a rational approach to enhance sulpiride absorption in the rat intestine.
    Baluom M; Friedman M; Assaf P; Haj-Yehia AI; Rubinstein A
    Pharm Res; 2000 Sep; 17(9):1071-6. PubMed ID: 11087038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma scintigraphic evaluation of film-coated tablets intended for colonic or biphasic release.
    Ofori-Kwakye K; Fell JT; Sharma HL; Smith AM
    Int J Pharm; 2004 Feb; 270(1-2):307-13. PubMed ID: 14726145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.